ArticleBreast cancer (Tokyo, Japan)2026

Characteristics of a multigene assay (MammaPrint/Blueprint) to predict early recurrence of hormone receptor-positive, HER2-negative breast cancer: a case‒control study (WJOG16722B).

Rurina Watanuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.